Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-099074
Filing Date
2024-08-20
Accepted
2024-08-20 16:05:33
Documents
1
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3180
  Complete submission text file 0000950170-24-099074.txt   4826
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 2401 FOURTH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Bencich John (Reporting) CIK: 0001477056 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 241225106